Catalent, Inc. CTLT is scheduled to report second-quarter fiscal 2023 results on Feb 7, before market open. In December 2022, Catalent announced the completion and opening of a new commercial-scale cell therapy manufacturing facility at its European center of excellence, in Gosselies, Belgium. Per the same call, management has been anticipating further repo effects from inflation, which has been impacting consumer confidence and discretionary spending.